WO2024093757A1 - Dispositif et système de neurostimulation pour une stimulation transcutanée du rameau auriculaire du nerf vague - Google Patents

Dispositif et système de neurostimulation pour une stimulation transcutanée du rameau auriculaire du nerf vague Download PDF

Info

Publication number
WO2024093757A1
WO2024093757A1 PCT/CN2023/126503 CN2023126503W WO2024093757A1 WO 2024093757 A1 WO2024093757 A1 WO 2024093757A1 CN 2023126503 W CN2023126503 W CN 2023126503W WO 2024093757 A1 WO2024093757 A1 WO 2024093757A1
Authority
WO
WIPO (PCT)
Prior art keywords
neurostimulation
user
stimulation
auricular
electrode
Prior art date
Application number
PCT/CN2023/126503
Other languages
English (en)
Inventor
Wai Kin Daniel KO
Original Assignee
Ko Wai Kin Daniel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ko Wai Kin Daniel filed Critical Ko Wai Kin Daniel
Publication of WO2024093757A1 publication Critical patent/WO2024093757A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation

Definitions

  • the present invention relates to an auricular neurostimulation device.
  • the invention further refers to an auricular neurostimulation system that comprises of the neurostimulation device that can be adapted, personalized and applied in synchronization with combined neurostimulation device (electrode assemblies) , according to the user’s requirements, as such having higher efficiency and stability for delivering stimulation.
  • the invention further relates to a method for operation and deliverance of such a neurostimulation system.
  • VN The Vagus Nerve
  • the VN is the longest cranial nerve and connects the brainstem to the body from the medulla to the colon and predominately innervates thoracic and abdominal organs, playing a key role in enabling the brain to regulate and monitor essential bodily functions and homeostasis.
  • the VN is a major component of parasympathetic regulation of the Autonomic Nervous System (ANS) and forms a neural circuit that regulates key physiology including heart rate, gastrointestinal motility, and secretion such as pancreatic secretion and glucose production.
  • ANS Autonomic Nervous System
  • the VN constitutes a bilateral neural structure extending from the brainstem through the neck, abdomen, and main organs with pivotal roles in both efferent and afferent functions.
  • the VN encompasses approximately 80-90%of afferent nerves.
  • These afferent pathways serve to transmit sensory information of the internal state of major organs to the Central Nervous System (CNS) .
  • This sensory feedback is integral to the function of the neuro-endocrine-immune axis that actively contributes to the maintenance of homeostasis.
  • These afferent pathways also engage with key components of physiological control, including the hypothalamic-pituitary-adrenal axis and the ANS.
  • the VN has extensive reciprocal connections that integrate and respond to feedback signals, with connections that extend to vital systems including cardiovascular, respiratory, gastrointestinal, autonomic, immune and endocrine functions.
  • the VN is mainly composed of cholinergic fibres, but also mediates non-cholinergic and non-adrenergic transmitters.
  • the VN enters the CNS via the Nucleus Tractus Solitarius (NTS) that extends through afferent projections to the parabrachial complex (PB) .
  • NTS Nucleus Tractus Solitarius
  • PB parabrachial complex
  • the PB forms connections with the Locus Coeruleus (LC) and Raphe Nuclei, where further ascending projections reach higher brain regions, regulating key brain processes.
  • LC Locus Coeruleus
  • Raphe Nuclei where further ascending projections reach higher brain regions, regulating key brain processes.
  • VNS Invasive cervical Vagus Nerve Stimulation
  • VNS The medical devices for VNS were first developed by Cyberonics Inc (now known as Livanova Inc) .
  • Other implantable medical devices for VNS have been developed that include:
  • VNS with implantable devices is an irreversible procedure that presents risks of infection (with approximately 3%incidence) and can cause potential nerve damage.
  • Voice alterations i.e., hoarseness during stimulation or cough pressure are risks tied to laryngeal recurrent nerve impact (with approximately 5%incidence) .
  • Other side effects of VNS treatment include dyspnea, local pain and abnormal muscle contractions and are caused by bi-directional stimulation of VN fibres.
  • tVNS Transcutaneous Vagus Nerve Stimulation
  • This method involves delivering electrical stimulation to the skin overlying the VN, offering neuromodulation without surgical intervention.
  • tVNS commonly utilizes a portable device applied to the neck or ear. The device’s electrical impulses activate nerve fibres under the skin, in turn stimulating the VN and transmitting signals to the brainstem and higher brain regions.
  • tVNS provides an effective low-risk alternative therapy with significant potential across various clinical applications.
  • tVNS can be achieved via activation of the Auricular Branch of Vagus Nerve (ABVN) and was first described by Ventureyra et al. (2000) .
  • the ABVN nerve extends to the pinna of the ear and can be electrically depolarized with minimal invasiveness.
  • tVNS at the cymba conchae induces activation of the primary termination sites of the main vagal sensory pathways, the spinal trigeminal nucleus and the Nucleus Tractus Solitary (NTS) (Frangos et al., 2015) .
  • the neurostimulation leads to activation of brainstem nuclei, such as the Locus Coeruleus (LC) and parabrachialis nucleus, and activation of mid-brain areas including the periaqueductal grey matter, dorsal raphe nucleus, substantia nigra and red nucleus (Frangos et al., 2015, Badran et al., 2017) .
  • brainstem nuclei such as the Locus Coeruleus (LC) and parabrachialis nucleus
  • mid-brain areas including the periaqueductal grey matter, dorsal raphe nucleus, substantia nigra and red nucleus
  • tVNS has been used in a range of clinical indications such as depression, anxiety, schizophrenia, autism, epilepsy (Rong, 2014; Stefan et al., 2012; Bauer et al., 2016) , migraine (Straube et al., 2015) , pre-diabetes (Huang et al., 2014) and post-ischemic stroke rehabilitation recovery (Baig et al., 2019; Redgrave et al., 2018) .
  • tVNS medical devices offer portability and user benefit from autonomy, customizable dosing, medication compatibility due to non-drug interactions and therefore lack of systemic side effects and/or development of treatment resistance.
  • Devices in the state of the art for ABVN stimulation include from Cerbomed, Nurosym from Parasym Ltd, from Nervana LLC and from Auri-Stim Medical, as well as others.
  • tVNS medical devices in prior art commonly target regions that are not exclusively supplied by the ABVN such as the cavity of conchae and tragus (for example Nurosym from Parasym Ltd) . It has been shown that the cymba conchae is the only anatomical location exclusively innervated by the ABVN (Peuker and Filler, 2002) .
  • the neurostimulation device by Cerbomed stimulates the cymba conchae (EP3100764 (A1) and DE102015007215 (B3) ) .
  • the devices are as a wired design, requiring physical connections for stimulation making the device inconvenient to use due to size and are not suited for continued application with a limited wear time for therapy.
  • the object of the invention introduces a wireless wearable neurostimulation device for tVNS stimulation of the nerve ramifications of the cymba conchae for ABVN neurostimulation, with increased efficiency, comfort, and offers personalization via feedback analyses from user data that can be adapted to each individual user’s needs.
  • a wearable auricular neurostimulation device This neurostimulation device (electrode assembly) is wireless and is intended for user wear for stimulation of the ABVN of the user’s ear.
  • the neurostimulation device incorporates at least one electrode positioned at the cymba conchae. The electrodes effectively utilize the entire cymba conchae to stimulate the ABVN when a voltage difference is applied.
  • the present invention refers to a neurostimulation device (1) that is wearable by a user and is configured to stimulate the Auricular Branch of Vagus Nerve (ABVN) of the user’s ear.
  • the invention further refers to a neurostimulation system that comprises of the neurostimulation device (electrode assembly) (1) and controller unit (8) .
  • the neurostimulation device (electrode assembly) (1) is wireless and comprises of at least 1 electrode (2) designed to be located in the cymba conchae, where the electrode stimulates the Ramus Auricularis Nervi Vagi (RANV) , when an electrical voltage difference is applied.
  • the neurostimulation device (electrode assembly) (1) comprises of at least 1 electrode (2) for generating a stimulating pulse, with the neurostimulation system having at least one detection means that is configured to detect one or more parameter values, and with the system having a controller unit (8) that is suitable to set one or more parameters of the stimulation pulse delivered by the neurostimulation device (electrode assembly) (1) based on parameter value or values.
  • the neurostimulation device (electrode assembly) (1) comprises of at least 1 electrode (2) and an infinity shape ( ‘figure of eight’ ) holding portion (3) that is designed to hold the electrode assembly at the ear of the user.
  • the invention further refers to a neurostimulation system for Auricular Branch of Vagus Nerve (ABVN) stimulation, having at least one electrode (2) for generating a stimulation pulse, wherein the neurostimulation system has at least one input device for inputting feedback data by the device user, wherein the neurostimulation system has memory in which the feedback data are stored or sent to a dedicated platform in the cloud, and where in the neurostimulation system has a controller unit (8) suitable to set one or more parameters of the stimulation pulse that is delivered wirelessly by the neurostimulation device (electrode assembly) (1) , or to provide adopted parameters of the stimulation pulse delivered by the neurostimulation device (electrode assembly) (1) for selection by the user.
  • ABSN Auricular Branch of Vagus Nerve
  • the success of the treatment delivered by the neurostimulation device (electrode assembly) (1) can take place in a manner specific to the user (personalized) or that the parameters that may influence stimulation, can determine a stimulation that increases the success of the treatment with respect to an unchangeable stimulation pattern i.e., stimulation protocol.
  • the invention further refers to a neurostimulation system for Auricular Branch of Vagus Nerve (ABVN) stimulation, that can be applied with 2 wireless neurostimulation devices (electrode assemblies) (1) concurrently, both generating a stimulation pulse, wherein the controller unit (8) of the neurostimulation system mediates synchronized or desynchronized stimulation of pulse parameters by the electrode assemblies.
  • ABSN Auricular Branch of Vagus Nerve
  • the electrodes are made from biocompatible materials (including titanium, nickel titanium, platinum and platinum-iridium, non-toxic metals such as gold) and biocompatible polymers for adaptation to user ear ergonomics for comfort, secure wear that is used for providing accurate positioning and contact to the stimulation area.
  • biocompatible materials including titanium, nickel titanium, platinum and platinum-iridium, non-toxic metals such as gold
  • biocompatible polymers for adaptation to user ear ergonomics for comfort, secure wear that is used for providing accurate positioning and contact to the stimulation area.
  • neurostimulation device (electrode assembly) fitting does not block the user’s ear canal i.e., does not impede auditory perceptions during use for carrying out ABVN stimulation.
  • the neurostimulation device is an inventive electrode assembly for nerve stimulation, in particular for ABVN stimulation that includes at least one electrode and an infinity shape ( ‘figure of eight’ ) holding portion which is designed to hold the electrode assembly at the ear of the user.
  • auricular neurostimulation device electrode assembly
  • two wireless stimulation electrodes for each of the user’s ears for bilateral ear stimulation, with the stimulation of each ABVN of the user that can be synchronized or unsynchronized.
  • the auricular neurostimulation device (electrode assembly) of the invention implements stimulation protocols based on waveform of rectangular, biphasic, and symmetric pulse forms.
  • the auricular neurostimulation device (electrode assembly) of the invention is configured to coordinate stimulation pulse or pulses with periodically occurring physiological processes, in particular neuro-physiological processes of the user.
  • the invention comprises of a smart-phone application that allows the user to interact with the neurostimulator.
  • the invention relates to an auricular neurostimulation system for ABVN stimulation comprising of the wireless neurostimulation device (electrode assemblies) and a controller unit, where the controller unit can recharge the internal battery of the neurostimulation device (electrode assemblies) when not performing neurostimulation.
  • the controller unit can be used by the user to control stimulation intensity of the neurostimulation device (electrode assemblies) .
  • the stimulation data performed by the neurostimulation device (electrode assemblies) is collected by the controller unit and can be sent to a dedicated platform in the cloud.
  • the controller unit and the connection to the internal application in the smartphone allows data transfer to an external cloud.
  • the controller unit communicates with the wireless neurostimulation device (electrode assemblies) for carrying out the ABVN stimulation.
  • the controller unit allows the user to increase stimulation intensity of the wireless neurostimulation device (electrode assemblies) for carrying out the ABVN stimulation.
  • the controller unit has a controller panel with a lighting display for ease of reference for the user to show the cumulated time of use, stimulation intensity, and the quality of skin contact to the ear.
  • the neurostimulation device includes a photoethysmogram (PPG) or biosensor, or having at least one external input mechanism for inputting feedback data by the device user to the controller unit of the neurostimulation system, for estimating levels of hemoglobin and oxy hemoglobin within the user’s circulation, where these data are used for calculating heart rate, HRV and breath rate and breathing phases of the user, or a parameter relating to the autonomic nervous system such as sympathovagal balance, or a parameter relating to movement activity or muscle response i.e. electromyography (EMG) , of the user or a combination of the aforesaid parameters.
  • PPG photoethysmogram
  • biosensor or having at least one external input mechanism for inputting feedback data by the device user to the controller unit of the neurostimulation system, for estimating levels of hemoglobin and oxy hemoglobin within the user’s circulation, where these data are used for calculating heart rate, HRV and breath rate and breathing phases of the user, or a parameter
  • the PPG or biosensor, or external input mechanism for data feedback is configured for detection of physiological markers such as low heart rate (bradycardia) and low breathing, in which case the stimulation will be stopped to avoid any health risks.
  • physiological markers such as low heart rate (bradycardia) and low breathing, in which case the stimulation will be stopped to avoid any health risks.
  • the neurostimulation system performing the ABVN stimulation treatment is configured with at least one wireless neurostimulation device (electrode assembly) for generating a stimulation pulse, with the neurostimulation system having at least one detection means that is configured to detect one or more parameter values, with the neurostimulation system having a controller unit that is suitable to set one or more parameters of the stimulation pulse delivered by the neurostimulation device (electrode assembly) based on detected parameter value or values.
  • the key advantage can thus be achieved with the stimulation provided being from a wireless neurostimulation device (electrode assemblies) , and also the success of the treatment can take place in a manner specific to the user (personalized) or that the parameters that may influence stimulation, can determine a stimulation that increases the success of the treatment with respect to an unchangeable stimulation pattern i.e., stimulation protocol.
  • the neurostimulation system also includes a cloud platform that can integrate data obtained from devices or sensors, such as watches, bracelets or rings, among other external sensors, for continuous monitoring of heart rate activity, sleep cycle patterns etc.
  • the analysis of these data allows, for example, to know the user’s physiological states and define personalized stimulation treatments that can improve negative ailments.
  • the invention pertains a method for operating the auricular neurostimulation system, encompassing the following sequential steps:
  • a. Setup phase the user inputs their personal information to create a profile (i.e., weight, age, medical history including symptom frequency and severity) and/or user’s baseline physiology readings are obtained at rest with external sensors including metrics for heart rate, HRV, breathing rate, and autonomic system activity for sympathovagal balance.
  • a profile i.e., weight, age, medical history including symptom frequency and severity
  • user baseline physiology readings are obtained at rest with external sensors including metrics for heart rate, HRV, breathing rate, and autonomic system activity for sympathovagal balance.
  • a stimulation protocol is designated to the user for unilateral, bilateral, synchronized or un-synchronized neurostimulation, that can be tailored to physiological, movement or muscle response (i.e., electromyography) trigger-activated neurostimulation.
  • Stimulation initiation Upon placing the device onto the user’s ears, the stimulation can be started.
  • the biosensor or an external input device collects user physiological data and is transmitted to the controller unit.
  • Stimulation session completion and data storage Once the stimulation is completed for the session, the controller unit stores the treatment session data.
  • the controller unit transmits the treatment session data to the cloud platform to facilitate subsequent analyses.
  • the cloud-based platform stores the treatment session data received.
  • Algorithmic analyses An algorithm analyses all the collected data, optimizing the stimulation parameters specific to individual users. Such optimized parameters are presented to the user and can be selected if preferred.
  • Figure 1 Illustration of the external ear anatomy that can be targeted for auricular neurostimulation in a human.
  • FIG. 1 A schematic diagram showing effects of Vagus Nerve Stimulation (VNS) .
  • VNS Vagus Nerve Stimulation
  • the Vagus Nerve (VN) activates ascending neural pathways leading to modulation of neural activity that can be stimulated via the Auricular Branch of Vagus Nerve (ABVN) .
  • the illustration shows the VN projects to the Nucleus Tractus Solitarii (NTS) , and Dorsal Motor Nucleus (DMN) , which further projects to higher brain regions including the locus coeruleus, hypothalamus, thalamus, basal ganglia, and forebrain cholinergic centers.
  • NTS Nucleus Tractus Solitarii
  • DN Dorsal Motor Nucleus
  • Figure 4 A view of the neurostimulation device (electrode assembly) according to the invention, in which the inclination between the connecting portion is inclined relative to the vertical center line (y-axis) of the infinity holding portion.
  • FIG. 1 The neurostimulation device (electrode assembly) according to the invention, in which the holding portion and the connecting portion are manufactured from materials of similar hardness.
  • FIG. 6 The neurostimulation device (electrode assembly) according to the invention that shows the bud attached that contains the electrical components that generates the electrical pulses to carry out nerve stimulation.
  • FIG. 7 The neurostimulation device (electrode assembly) according to the invention on a side view.
  • FIG. 1 A view of the neurostimulation system’s controller unit according to the invention.
  • Figure 9 A view of the placement of the neurostimulation device (electrode assemblies) into the controller case, in which the holding portion is contained and connected to the controller unit through copper pogo pins that recharge the neurostimulation device (electrode assemblies) .
  • FIG. 10 The neurostimulation device (electrode assemblies) stimulation for bilateral ear stimulation, in configurations for 10A. synchronized or 10B. unsynchronized neurostimulation of the ABVN.
  • Figure 11 The user flow for setup of user account, device setup, data analysis and feedback of the neurostimulation system.
  • the object of the invention is an auricular neurostimulation device (electrode assembly) (1) wearable by a user that optimizes the stimulation of ABVN at the cymba conchae, as illustrated in Figure 1.
  • the neuroanatomy of ABVN stimulation is shown in Figure 2.
  • Neurostimulation at the ABVN via cymba conchae mediates stimulation of the Ramus Auricularis Nervi Vagi (RANV) , activating the vagus nerve pathways to the NTS and DMN, and then activates the projections of higher brain regions that include the locus coeruleus, hypothalamus, thalamus, basal ganglia and forebrain.
  • RNSV Ramus Auricularis Nervi Vagi
  • the auricular neurostimulation device (electrode assembly) (1) of the invention is composed of the following components, as represented in Figure 4, designed for placement into the user’s ear:
  • the device incorporates a minimum of one electrode (2) positioned in the cymba conchae (the only ear zone with 100%ABVN) and is configured as a working electrode.
  • both electrodes are configured as working electrodes for application of a voltage potential for optimizing the activation of the ABVN.
  • electrodes are typically manufactured from biocompatible materials (including titanium, nickel titanium, platinum and platinum-iridium, non-toxic metals such as gold) and biocompatible polymers for adaptation to the user’s ears for comfort, secure wear for providing accurate positioning and contact to the stimulation area. Further, electrode fitting does not block the ear canal i.e. does not impede auditory perceptions during use for carrying out ABVN stimulation.
  • the auricular neurostimulation device (electrode assembly) (1) is integrated with electronic circuits enabling the following functionalities:
  • EMG electromyography
  • neurostimulation device (electrode assembly) (1) protects the electronic circuits while ensuring ease, convenience, and stable placement into the users ear, or into the controller unit (12) .
  • the auricular neurostimulation device (electrode assembly) (1) implements a range of stimulation protocols.
  • the stimulation protocols are based on waveform of rectangular, biphasic, symmetrical, and are synchronized for bilateral ABVN neurostimulation ( Figure 10A) . This configuration is used to elicit the desired physiological effect of activations of nerve endings of ABVN fibres with higher efficiency.
  • the stimulation protocols include burst stimulation for elevating endogenous responsiveness of ABVN nerve endings. Burst stimulation act to disrupt endogenous neural activities for heighted response that includes 1-20 bursts per second.
  • stimulation protocols offer variations in parameters of pulse shape, pulse width, pulse frequency for user comfort and optimized stimulation.
  • the stimulation intensity is adjustable between 0 and 3 mA.
  • the pulse width determines engagement of specific ABVN fibres which includes A ⁇ A ⁇ and C (Safi et al., 2016) .
  • Short pulses waves of 10-300 ⁇ s are used to engage thick fibres of A ⁇ and avoid inductions of A ⁇ and C fibres, which transmit pain signals.
  • the recruitment of desirable thick fibres are also dependent on frequency where 1-100 Hz are used.
  • auricular neurostimulation device (electrode assembly) (1) of this invention provides a compact, lightweight form-factor to ensure wearer comfort.
  • the wireless auricular neurostimulation device (electrode assembly) (1) configuration and ear ergonomic design ensures the avoidance of ear canal obstruction or hinderance of auditory perceptions.
  • the auricular neurostimulation device (electrode assembly) design allows for association with familiar products that facilitate user adoption and wireless data transfer further supports user convenience ( Figure 3) . Furthermore, the ergonomic design of the auricular neurostimulation device (electrode assemblies) (1) ensures for stable placement into the users’ ears that ensures good quality contact between electrodes (2) and the ABVN stimulation region.
  • the neurostimulation device (electrode assembly) (1) is an inventive electrode assembly for nerve stimulation, in particular for ABVN stimulation that includes at least one electrode (2) and an infinity shape ( ‘figure of eight’ ) holding portion (3) which is designed to hold the electrode assembly at the ear of the user.
  • the at least one electrode (2) preferably is connected to the holding portion of the infinity shape ( ‘figure of eight’ ) (3) via a connecting portion (4) , wherein the connecting portion is inclined relative to the vertical center line (y-axis) of the infinity holding portion, at an angle of preferably about 10° to 40°, particularly preferably at about 30° ( Figure 4) .
  • the holding portion (3) and the connecting portion (4) are manufactured from materials of similar hardness, in particular from materials with a Shore hardness in the range of about 60 Shore A to about 90 Shore A, particularly preferably in the range of about 70 Shore A to about 90 Shore A.
  • the holding portion (3) is largely manufactured from a relatively soft material and the connecting portion (4) as well as a section of the holding portion adjoining the connecting portion can also be manufactured from materials of different hardness, wherein preferably the part manufactured from a relatively hard material is inserted, embedded, or sunk in the part manufactured from a relatively soft material.
  • the advantages of a good structure stability of the neurostimulation device (electrode assembly) (1) as a result of relatively hard materials can be combined with an increased wearing comfort due to relative soft materials.
  • the part made of relatively hard material is inserted, embedded or sunk in the part made of relatively soft material or vice versa.
  • This provides for generating a smooth surface, which increases the wearing comfort of the neurostimulation device (electrode assembly) (1) and also has hygienic advantages.
  • the holding portion can include such a framework which is sheathed with a softer material.
  • the neurostimulation device (electrode assembly) (1) includes two electrode contacts (2) .
  • the electrode contacts (2) are made of coated titanium.
  • Another advantage of the present neurostimulation device (electrode assembly) (1) consists in that the at least one electrode (2) and the infinity shape ( ‘figure of eight’ ) holding portion (3) are arranged such that the access of the auditory canal of the users is not completely blocked and does not impede hearing when the neurostimulation device (electrode assembly) (1) is arranged in the ear of the user.
  • the second ring, the lower part of the holding portion of the infinity shape ( ‘figure of eight’ ) (3) sits in the ear canal of the user.
  • An additional full circle ring may be attached to the inner part of the lower portion (5) , allowing further support for the neurostimulation device (electrode assembly) (1) to be secured into the ear of the user.
  • the holding portion of the infinity shape (3) is tucked into the ear with sufficient contact pressure, and a safe contact of the electrode contacts (2) with the skin of the user is ensured.
  • the neurostimulation device (electrode assembly) (1) supports good contact of electrode contacts (2) with the cymba conchae to maximize effects of stimulation.
  • the advantage of the shape is that the lower portion of the infinity shape fits in the ear canal (5) but does not block or hinder the user’s hearing to environmental sounds and therefore can be used for long durations and long wear times.
  • the neurostimulation device (electrode assembly) (1) in one embodiment includes two electrodes (2) and an infinity shape ( ‘figure of eight’ ) holding portion (3) .
  • the two electrodes are connected to the infinity shape ( ‘figure of eight’ ) holding portion via connecting portion (4) .
  • the infinity shape ( ‘figure of eight’ ) holding portion (3) can include a full circle ring that can be attached to the inner part of the lower portion (5) .
  • the hollow center ensures it does not impede the auditory perceptions of the user to surrounding sounds of the environment.
  • the infinity shape ( ‘figure of eight’ ) holding portion (3) includes a bud (6) containing electrical components connected to the holding portion of the infinity shape ( ‘figure of eight’ ) (3) that generates the electrical pulses to carry out ABVN neurostimulation.
  • -A cable associated with the electrode can be arranged in the holding portion (3) .
  • the two electrodes (2) are positioned symmetrical to one another relative to the center-line (y-axis) of the holding portion of the infinity shape ( ‘figure of eight’ ) ( Figure 4) .
  • a large part of the holding portion is made of relatively soft material, it may be advantageous to provide the necessary rigidity by means of a framework/inlay made of a relatively hard material inserted into the holding portion (4) .
  • the auricular neurostimulation device (1) of the invention targets the cymba conchae only, which is the only region of the ear where 100%nerve endings are from the ABVN.
  • the auricular neurostimulation devices in this state of art only Cerbomed stimulates the cymba at one ear (unilateral) .
  • the present invention facilitates concurrent bilateral neurostimulation of the ABVN with either synchronized or unsynchronized stimulation ( Figure 10) .
  • the present invention detects sufficient skin conduction to ensure quality contact for efficient neurostimulation.
  • the invention relates to an auricular neurostimulation system for ABVN stimulation comprising of the wireless neurostimulation device (electrode assemblies) (1) and a controller unit (8) , where the controller unit can recharge the internal battery of the neurostimulation device (electrode assemblies) when not performing neurostimulation (12) .
  • the controller unit (8) can be used by the user to control stimulation intensity (9) of the neurostimulation device (electrode assemblies) (1) .
  • the stimulation data performed by the neurostimulation device (electrode assemblies) (1) is collected by the controller unit (8) and can be sent to a dedicated platform in the cloud.
  • the controller unit and the connection to the internal application in the smartphone allows data transfer to an external cloud ( Figure 3) .
  • the neurostimulation device includes a photoethysmogram (PPG) or biosensor, or having at least one external input mechanism for inputting feedback data by the device user to the controller unit (8) of the neurostimulation system, for estimating levels of hemoglobin and oxy hemoglobin within the user’s circulation, where these data are used for calculating heart rate, HRV and breath rate and breathing phases of the user, or a parameter relating to the autonomic nervous system such as sympathovagal balance, or a parameter relating to movement activity or muscle response i.e. electromyography (EMG) , of the user or a combination of the aforesaid parameters.
  • PPG photoethysmogram
  • biosensor or having at least one external input mechanism for inputting feedback data by the device user to the controller unit (8) of the neurostimulation system, for estimating levels of hemoglobin and oxy hemoglobin within the user’s circulation, where these data are used for calculating heart rate, HRV and breath rate and breathing phases of the user, or
  • the PPG or biosensor, or external input mechanism for data feedback is configured for detection of physiological markers such as low heart rate (bradycardia) and low breathing, in which case the stimulation will be stopped automatically to avoid any health risks.
  • physiological markers such as low heart rate (bradycardia) and low breathing, in which case the stimulation will be stopped automatically to avoid any health risks.
  • the measurements taken by the sensor or from inputted data make it possible to provide adapted stimulation protocols that can achieve optimal vagal stimulation for the device user. This allows personalized stimulation treatments to the device user for reaching efficient ABVN neurostimulation that is much higher in effectiveness than other existing devices known in the art.
  • the PPG or biosensor, or external input mechanism for data feedback functions to detect parameters related to the autonomic nervous system such as sympathovagal balance, or a parameter relating to movement activity or muscle response i.e., electromyography (EMG) , of the user.
  • EMG electromyography
  • the auricular neurostimulation device (electrode assemblies) (1) are stored into the controller unit (8) that holds and recharges the neurostimulation device (electrode assemblies) (1) through pogo pins (7) (11) ( Figure 9) .
  • the controller unit (8) captures the data from the neurostimulation device (electrode assemblies) (1) and sends to a dedicated platform in the external cloud.
  • the neurostimulation system has a smartphone application that allows the user to engage with the auricular neurostimulation device (electrode assemblies) (1) and controller unit (8) , for user reference and configurations of specific stimulation parameters.
  • the mobile app establishes interchange of data with a dedicated platform in the cloud, receiving the data captured by the PPG or biosensor, and/or external input mechanism for data feedback, during stimulation sessions.
  • the neurostimulation system controller unit (8) of the invention is configured to detect parameters related to heart rate, HRV, and breath rate and breathing phases of the user, or a parameter relating to the autonomic nervous system such as sympathovagal balance, or a parameter relating to movement activity or muscle response i.e., electromyography (EMG) , of the user or a combination of the aforesaid parameters.
  • An adopted stimulation protocol can be assigned to the user for selection based on the user profile and feedback data received to achieve improved efficiency in activation of the user’s vagus nerve.
  • the auricular neurostimulation device (electrode assemblies) (1) of the invention offers distinct advantages over known neurostimulation devices in the state of the art, with respects to usability, stability and comfort, efficiency, safety, and customization.
  • the PPG or biosensor, or external input mechanism for data feedback collected from the neurostimulation system of continuous monitoring of cardiac activity patterns through external wearables such as watches, bracelets and rings, is configured for detection of physiological markers such as low heart rate (bradycardia) and low breathing, in which case the neurostimulation will be stopped to prevent health risks.
  • Customization –the neurostimulation system of the invention includes therapeutic customization for selection of stimulation protocols personalized based on the user profile and feedback data received, that can be synchronized with the autonomic nervous system such as sympathovagal balance, and/or parameters relating to movement activity or muscle response i.e., electromyography (EMG) , of the user.
  • EMG electromyography
  • the neurostimulation system performing the ABVN stimulation treatment is configured with at least one electrode (2) for generating a stimulation pulse and can be delivered wirelessly, with the neurostimulation system having at least one detection means that is configured to detect one or more parameter values, with the neurostimulation system having a controller unit (8) that is suitable to set one or more parameters of the stimulation pulse delivered by the electrode (2) based on detected parameter value or values.
  • the stimulation protocols performed by the neurostimulation system can be modified/personalized to the user. With respect to one or more parameters such as the duration or strength of the pulse, it is rather dependent on one or more parameter values that are measured by external sensors.
  • the key advantage can thus be achieved with the stimulation provided being from a wireless auricular neurostimulation device (electrode assembly) (1) , and also the success of the treatment can take place in a manner specific to the user (personalized) or that the parameters that may influence stimulation, can determine a stimulation that increases the success of the treatment with respect to an unchangeable stimulation pattern i.e., stimulation protocol.
  • the detection means are preferably configured in the form of one or more sensors.
  • the detection means can be configured to measure the parameter value or values such as the heart rate of the user in real time and the neurostimulation system controller unit (8) can be configured to set the stimulation pulse based on the parameter value or values measured in real time.
  • the detection means can be connected to a memory such that the parameter values measured by the detection means are stored in the memory and such that the neurostimulation system controller unit (8) is configured to set the stimulation pulse based on the parameter value or values stored in the memory. It would, for example, be conceivable that the data for physiological recordings such as heart rate and sleep cycle patterns are determined and stored over a longer period and that the stimulation pulse is delivered by the neurostimulation device (electrode assembly) (1) can be on the basis of stored values.
  • the user parameters or parameters can be physiological signals of the user such as heart rate, breathing, sleep cycle patterns, that can be determined by means of an external sensor, a parameter for breathing, or a parameter relating to the autonomic nervous system such as sympathovagal balance, or a parameter relating to movement activity or muscle response i.e., electromyography (EMG) , of the user or a combination of the aforesaid parameters.
  • EMG electromyography
  • the neurostimulation system controller unit (8) is configured to control the wireless auricular neurostimulation device (electrode assembly) (1) such that the parameter value detected by means of the detection is adjusted to a desired value (9) or to a desired value range by means of the stimulation pulse.
  • the neurostimulation system could be configured such that the ABVN stimulation influences the autonomic nervous system i.e., sympathovagal balance. If the vagal tone is directly detected i.e., through external sensors or by other means, the neurostimulation system controller unit (8) can be configured such that it specifically influences the stimulation of the neurostimulation device (electrode assembly) (1) and adapts the vagal tone to a desired value or desired value range.
  • the neurostimulation device electrode assembly
  • the neurostimulation system controller unit (8) is configured to coordinate the stimulation pulse or pulses with periodically occurring physiological processes, in particular neuro-physiological processes of the user.
  • a stimulation pulse is generated by means of at least one wireless neurostimulation device (electrode assembly) (1) , with one or more parameter values being detected in advance and with one or more parameters of the stimulation pulse delivered by the wireless neurostimulation device (electrode assembly) (1) being set by a neurostimulation system controller unit (8) based on the parameter value or values.
  • the neurostimulation system in accordance with this invention for adaptive neurostimulation i.e., providing stimulation protocol that is not fixed or identical, but is based on one or more parameters specific to the user.
  • the present invention thus comprises of an evolved application from conventional ABVN neurostimulators, with various sensors that serve as input for control or variation of stimulation parameters.
  • a closed loop application is conceivable with regulation of a parameter to a desired value or in a desired value range.
  • the auricular neurostimulation device (electrode assemblies) (1) are controlled by wireless connectivity by the neurostimulator system controller unit (8) .
  • the controller unit can connect by wireless connectivity (e.g., Bluetooth) to external devices via a smartphone application, which in turn is connected to software in the cloud ( Figure 3) . Through this connectivity the stimulation session data from the neurostimulation device electrode assemblies (1) can be transferred.
  • the auricular neurostimulation device (electrode assemblies) (1) are controlled by a neurostimulation system controller unit (8) for convenience and ease of use for the user.
  • the neurostimulator system controller unit (8) has the size of a smartphone.
  • the neurostimulation system controller unit (8) communicates with the wireless neurostimulation device (electrode assemblies) (1) for carrying out the ABVN stimulation.
  • the neurostimulation system controller unit (8) allows the user to increase stimulation intensity of the wireless neurostimulation device (electrode assemblies) (1) for carrying out the ABVN stimulation.
  • the neurostimulation system controller unit has a controller panel (9) with lighting display for ease of reference for the user to show the cumulated time of use, the stimulation intensity, and the quality of skin contact to the ear.
  • the neurostimulation device (electrode assemblies) are placed in an allocated position (10) in the neurostimulation system control unit (8) for recharging (12) .
  • the allocated position is constructed to contain the infinity shape ( ‘figure of eight’ ) neurostimulation device (electrode assemblies) (10) .
  • At least one neurostimulation device (electrode assembly) (1) is placed in the controller unit (8) , there is recharge of the battery of the neurostimulation device (electrode assembly) .
  • a neurostimulation system controller unit (8) that includes user panel for adjusting stimulation by the user (9) .
  • the neurostimulation device (electrode assemblies) can be placed in the allocated position to hold the neurostimulation device (electrode assemblies) (12) .
  • the connection between the neurostimulation system controller unit (8) and the neurostimulation device (electrode assemblies) (1) are via two copper pogo pins that initiate the recharge (11) , when the neurostimulation device (electrode assemblies) are placed into the neurostimulation system controller unit (12) as shown in Figure 9.
  • the neurostimulation system controller unit (8) for ABVN stimulation is configured with at least one wireless neurostimulation device (electrode assembly) (1) that generates a stimulating pulse, wherein the neurostimulation system has at least one input device for inputting feedback data by the device user, wherein the neurostimulation system has a memory in which the feedback data are stored, and wherein the neurostimulation system can be adjusted to set one or more parameters of the stimulation pulse delivered by the wireless neurostimulation device (electrode assemblies) (1) , that is dependent on user feedback or to propose the parameters of the stimulation pulse delivered by the neurostimulation device (electrode assemblies) (1) for a selection by the device user.
  • the electrical components of the neurostimulation system controller unit (8) are comprised of an electrical circuit that allows the following functionalities:
  • EMG electromyography
  • the effect of the neurostimulation system is optimized by feedback of the users while taking account of defined parameters.
  • the neurostimulation system controller unit (8) for ABVN stimulation knows the defined parameters of the stimulation delivered by the wireless neurostimulation device (electrode assemblies) (1) and learns by the feedback of the user or users whether these parameters have been detrimental i.e., any negative effects on physiological state such as dizziness, pain, or whether the ailment has worsened. Based on the feedback, the neurostimulation system controller unit (8) can change the stimulation pulse of the wireless neurostimulation device (electrode assemblies) (1) for following treatments for improving the condition i.e., optimization based on feedback data.
  • the technical settings of the neurostimulation system controller unit (8) such as pulse duration, intensity, time of use, are set based on the feedback of the device user or users or proposed for setting by the user so that he/she can decide whether to activate this proposed setting.
  • the feedback data stored in the memory of the neurostimulation system are individual to the user. This means that an optimization of the stimulation individual to the user is carried out.
  • the feedback data stored in the memory of the neurostimulation system are not individual to the user, but rather relates to all device users for the particular disease or related condition.
  • the memory in which the feedback data are stored can be an integral component of the neurostimulation system or can be arranged as an external device component. This also applies in another respect to all the other components of the system.
  • the ‘neurostimulation system’ can be understood as a system of components that do not necessarily have to be arranged at one and the same location.
  • the memory can thus, for example, be formed as a data pool by a server that is spatially separate from that part of the device the user actuates.
  • the neurostimulation system can have one or more external sensors by means of which one or more user parameters and/or external parameters can be detected, with the neurostimulation system controller unit (8) being configured also to set one or more parameters of the stimulation pulse that is delivered by the wireless neurostimulation device (electrode assemblies) (1) based on the user parameters and/or on the external parameters or to propose the parameters of the stimulation pulse delivered by the wireless neurostimulation device (electrode assemblies) (1) for selection by the user.
  • these parameters such as heart rate parameters, sleep cycles, stress, physical activity, movement, muscle response etc., also enter into the parameter values of the stimulation pulse.
  • a method for the neurostimulation system for performing ABVN stimulation treatment that can be with feedback data stored in a memory that are input by the device user by means of an input device and that are one or more parameters of the stimulation pulse delivered by the wireless neurostimulation device (electrode assemblies) (1) are set based on the feedback data or are proposed for selection to the user.
  • the collected data and the feedback data forms a data pool.
  • This data pool has to be analyzed in particular for positive or negative correlations between the variables with respect to their effects on the perceived well-being or perceived change in negative state.
  • the user downloads the mobile application on their smartphone and creates an account on the system.
  • the user is prompted to input accurate personal data including (i.e., weight, age, medical history including symptom frequency and severity) .
  • accurate personal data including (i.e., weight, age, medical history including symptom frequency and severity) .
  • a suitable stimulation protocol is assigned depending on the user’s profile based on data groups and statistical studies.
  • the analysis of the data captured by PPG or biosensor, or external input mechanism for data feedback allows these stimulation protocol to be customized.
  • the user Upon successful account registration, the user proceeds to log into the application to establish a connection with the auricular neurostimulation device. Through the mobile application, the user is prompted to scan the QR code that is unique to the auricular neurostimulation device. This connection facilitates the assignment of the device’s serial number with the user account.
  • the user selects a stimulation protocol from those available depending on his/her needs (unilateral, bilateral, synchronized or un-synchronized, and/or physiological or movement or muscle response i.e., electromyography (EMG) triggered) .
  • EMG electromyography
  • the mobile app sends the data of the protocol selected to the neurostimulation system controller unit (8) .
  • the controller unit Upon user placement of the wireless neurostimulation device (electrode assemblies) (1) following removal from the neurostimulation system controller unit (8) , the controller unit will automatically detect for sufficient skin contact via the neurostimulation device (electrode assemblies) (1) integrated sensor. If the neurostimulation device (electrode assemblies) (1) are well placed in the user’s ear and the impedance of electrode contacts (2) with the ABVN area is good, the neurostimulation system will allow the user to start stimulation using the neurostimulation system controller unit (8) .
  • the neurostimulation system controller unit monitors the stimulation intensity and duration of use (9) .
  • maximum stimulation time elapses, or if electrode skin contact is compromised, or when the user takes off the neurostimulation device (electrode assemblies) (1) and re-inserts to the neurostimulation system controller case (12) , the stimulation stops automatically.
  • the PPG or biosensor data, or data collected from external input devices, of the user’s physiological metrics is transmitted to the neurostimulation system via Bluetooth.
  • the neurostimulation system controller unit (8) stores the session data (including date, time, stimulation duration, stimulation parameters and user’s physiological metrics) .
  • the batteries of the neurostimulation device (electrode assemblies) (1) are recharged with return to the neurostimulation system controller unit (8) .
  • the neurostimulation system controller unit (8) transmits the data of each stimulation session to the mobile application. From here, the mobile application sends the data to the cloud for analyses.
  • the cloud-based platform stores the user data sessions.
  • An algorithm systematically processes all user-specific data. If a more suitable stimulation protocol is available based on the user’s profile, the platform sends the values to the application, so that the optimized stimulation protocol can be selected if the user wishes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)

Abstract

La présente invention concerne un dispositif de neurostimulation (1) qui peut être porté par un utilisateur pour stimuler le rameau auriculaire du nerf vague (RANV) de l'oreille de l'utilisateur. Le dispositif (1) est sans fil et comprend : au moins 1 électrode (2) conçue pour être située dans la cymba conchae pour la stimulation du rameau auriculaire du nerf vague (RANV) lorsqu'une différence de tension électrique est appliquée ; et une partie de maintien de forme infinie (3) conçue pour maintenir le dispositif à l'oreille de l'utilisateur. L'invention concerne en outre un système de neurostimulation qui comprend le dispositif sans fil (1) et une unité de commande (8), le système de neurostimulation ayant au moins un moyen de détection conçu pour détecter une ou plusieurs valeurs de paramètres, des données de retour d'informations étant envoyées à une plateforme en nuage dédiée, et le système étant approprié pour régler des paramètres de la neurostimulation délivrée par le dispositif (1) sur la base de valeurs de paramètres de retour d'informations.
PCT/CN2023/126503 2022-10-31 2023-10-25 Dispositif et système de neurostimulation pour une stimulation transcutanée du rameau auriculaire du nerf vague WO2024093757A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263420809P 2022-10-31 2022-10-31
US63/420,809 2022-10-31

Publications (1)

Publication Number Publication Date
WO2024093757A1 true WO2024093757A1 (fr) 2024-05-10

Family

ID=90929677

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/126503 WO2024093757A1 (fr) 2022-10-31 2023-10-25 Dispositif et système de neurostimulation pour une stimulation transcutanée du rameau auriculaire du nerf vague

Country Status (1)

Country Link
WO (1) WO2024093757A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140257438A1 (en) * 2011-08-31 2014-09-11 ElectroCore, LLC Systems and methods for vagal nerve stimulation
CN109718470A (zh) * 2019-01-25 2019-05-07 江西心之乐医疗科技有限公司 一种入耳式无创耳迷走神经刺激仪及其脉冲输出方法
CN114980956A (zh) * 2019-11-20 2022-08-30 赛纳斯蒂姆责任有限公司 耳神经刺激装置及系统

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140257438A1 (en) * 2011-08-31 2014-09-11 ElectroCore, LLC Systems and methods for vagal nerve stimulation
CN109718470A (zh) * 2019-01-25 2019-05-07 江西心之乐医疗科技有限公司 一种入耳式无创耳迷走神经刺激仪及其脉冲输出方法
CN114980956A (zh) * 2019-11-20 2022-08-30 赛纳斯蒂姆责任有限公司 耳神经刺激装置及系统

Similar Documents

Publication Publication Date Title
JP7470160B2 (ja) 末梢神経刺激による心機能不全の治療のためのシステムおよび方法
CN108697890B (zh) 一种通过同步激活神经治疗各种神经疾病的系统和方法
US11298535B2 (en) Non-invasive vagus nerve stimulation
EP3693053B1 (fr) Dispositif de neurostimulation auriculaire et système
US9248286B2 (en) Medical self-treatment using non-invasive vagus nerve stimulation
EP2658602B1 (fr) Thérapie cardio-neuronale utilisant l'impédance électrique
CN111447969A (zh) 用于影响副交感神经和交感性神经活动以达到治疗效果的周围神经刺激装置
JP7334257B2 (ja) 神経伝達システム
US20210379374A1 (en) Nerve stimulation for treating migraine and other headache conditions
CN109069828A (zh) 用于头痛的非侵入性治疗的系统和方法
JP2022502139A (ja) 患者の疾患に対処するための耳介神経刺激、並びに関連するシステム及び方法
AU2008318432A1 (en) Automated fitting system for deep brain stimulation
US11642516B2 (en) Neuronal signal system for behavior modification
CA2898342C (fr) Autotraitement medical utilisant une stimulation non invasive du nerf vague
CN117085248A (zh) 一种治疗神经源性体位性低血压的经皮脊髓电刺激设备
WO2021028866A1 (fr) Dispositifs de stimulation binaurale synchrone des nerfs vestibulaires
WO2024093757A1 (fr) Dispositif et système de neurostimulation pour une stimulation transcutanée du rameau auriculaire du nerf vague
CN108712920B (zh) 对肌肉位置识别和治疗反应增强有效的电刺激设备
EP4351703A1 (fr) Système pour applications de neuromodulation